Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Belmar Pharmacy / Belmar Pharma Solutions
Legal identity not verified in the bound record
4 citations2 action records7 explicit unknowns
Locations in the source record
- 12860 W Cedar Dr Ste 210, Lakewood, CO 80228
Services named by sources
- 503A patient-specific compounding
- 503B outsourcing services claimed by brand
- Personalized medications
- Bioidentical hormone replacement therapy
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
Belmar describes the organization as a 503A and 503B compounding pharmacy. Section 503A is statutory, not FDA registration.
Section 503B
Not conclusively established
The current FDA-registry extraction did not expose an exact Belmar row, so the first-party 503B brand statement was not upgraded to FDA-verified facility status.
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
Actions stay dated and bounded.
FDA exact-name search identified the 2015 Form 483 and 2016 state referral. State-board discipline and later federal actions were not exhaustively verified.
U.S. Food and Drug Administration · 2015-06-18
Form FDA 483
FDA documented inspection observations after a June 10–18, 2015 inspection. A Form 483 records inspection observations and is not itself a final agency determination.
issuedU.S. Food and Drug Administration · 2016-12-05
State Referral Letter
FDA notified the Colorado Board of Pharmacy that FDA did not intend to take further action regarding the inspection.
issued_to_colorado_boardWhat remains unverified
- Exact legal entities and facility mapping
- FDA-verified current 503B facility row
- Full state-license roster
- Semaglutide relevance
- Tirzepatide relevance
- Founded year
- Current state-board disciplinary status
Patient reviews
Share your experience for moderationNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
3 evidence dimensions carry dated, source-backed verification.
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
- dated source ledger: 4 first-party/regulator citations with URL, accessed date, and exact supporting quote.
- regulatory action timeline: 2 dated regulatory/action record(s) with bounded summaries and regulator citations.
- transparent unknowns: 7 unresolved field(s) are explicitly named and prevented from rendering as facts.
No superiority claim is made for review volume, ratings, or patient sentiment.
Sources and exact captured wording
- first_party · accessed 2026-08-20
Your trusted 503A and 503B compounding pharmacy partner providing quality medications and bioidentical hormones formulated for individual patients’ health needs.
- fda · accessed 2026-08-20
Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to determine conformance to such requirements.
- fda · accessed 2026-08-20
The purpose of this letter is to notify the Colorado State Board of Pharmacy (BOP) that the U.S. Food and Drug Administration does not intend to take further action with regard to an inspection of a pharmacy licensed by the Colorado BOP, Belmar Pharmacy, located at 12860 W. Cedar Drive, Suite 210, Lakewood, CO 80228 (License #: PDO.0730000018).
- fda · accessed 2026-08-20
Updated as of 8/18/2026
Questions readers ask
Is Belmar Pharmacy / Belmar Pharma Solutions legit?
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 4 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 7 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.